Making the most of surveillance studies : Summary of the OPTAMA ProgramKUTI, Joseph L; NICOLAU, David P.Diagnostic microbiology and infectious disease. 2005, Vol 53, Num 4, pp 281-287, issn 0732-8893, 7 p.Article

Meropenem decreases serum level of valproic acidNACARKUCUK, Ergun; SAGLAM, Halil; OKAN, Mehmet et al.Pediatric neurology. 2004, Vol 31, Num 3, pp 232-234, issn 0887-8994, 3 p.Article

Contribution des données PK/PD dans la construction des schémas posologiques du méropénème : analyse critique = Contribution of PK/PD data in the development of the dosing regimen for meropenem : a critical analysisPETITJEAN, O; NICOLAS, P; JACOLOT, A et al.La Lettre de l'infectiologue. 2008, Vol 23, Num 1, pp 11-18, issn 0296-9009, 8 p., SUPArticle

Chromatographic determination of polymerized impurities in meropenemCAIN, Shan-Ying; HU, Chang-Qin.Journal of pharmaceutical and biomedical analysis. 2005, Vol 37, Num 3, pp 585-589, issn 0731-7085, 5 p.Article

Intrapulmonary pharmacokinetics and pharmacodynamics of meropenemCONTE, John E; GOLDEN, Jeffrey A; KELLEY, Mary Grace et al.International journal of antimicrobial agents. 2005, Vol 26, Num 6, pp 449-456, issn 0924-8579, 8 p.Article

Doripenem : antimicrobial profile and clinical potentialLIVERMORE, David M.Diagnostic microbiology and infectious disease. 2009, Vol 63, Num 4, pp 455-458, issn 0732-8893, 4 p.Article

Optimizing antimicrobial pharmacodynamics: Dosage strategies for meropenemMATTOES, Holly M; KUTI, Joseph L; DRUSANO, George L et al.Clinical therapeutics. 2004, Vol 26, Num 8, pp 1187-1198, issn 0149-2918, 12 p.Article

CarbapenemsBREILH, Dominique; TEXIER-MAUGEIN, Jeannette; ALLAOUCHICHE, Bernard et al.Journal of chemotherapy (Testo stampato). 2013, Vol 25, Num 1, pp 1-17, issn 1120-009X, 17 p.Article

Use of a program-specific website to disseminate surveillance data obtained from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) StudyTURNER, Philip J.Diagnostic microbiology and infectious disease. 2005, Vol 53, Num 4, pp 273-279, issn 0732-8893, 7 p.Article

Continuous Epileptiform Discharges in Patients Treated With Cefepime or MeropenemNAEIJE, Gilles; LORENT, Sophie; VINCENT, Jean-Louis et al.Archives of neurology (Chicago). 2011, Vol 68, Num 10, pp 1303-1307, issn 0003-9942, 5 p.Article

Carbapénèmes: nouvelles molécules, différentes indications ? = Carbapenems: new molecules, different indications?ZAHAR, J. R; GRALL, I; KOUATCHET, A. T et al.La Lettre de l'infectiologue. 2010, Vol 25, Num 4, pp 142-146, issn 0296-9009, 5 p.Article

Activité in vitro du méropénème = Meropenem : in vitro activityJOLY-GUILLOU, M. L.La Lettre de l'infectiologue. 2008, Vol 23, Num 1, pp 6-10, issn 0296-9009, 5 p., SUPArticle

Susceptibility of meropenem and comparators tested against 30,634 Enterobacteriaceae isolated in the MYSTIC Programme (1997-2003)TURNER, Philip J.Diagnostic microbiology and infectious disease. 2004, Vol 50, Num 4, pp 291-293, issn 0732-8893, 3 p.Article

Antimicrobial resistance rates and clonality results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme: Report of year five (2003)RHOMBERG, Paul R; JONES, Ronald N; SADER, Helio S et al.Diagnostic microbiology and infectious disease. 2004, Vol 49, Num 4, pp 273-281, issn 0732-8893, 9 p.Article

Safety and Effectiveness of Meropenem in Infants With Suspected or Complicated Intra-abdominal InfectionsCOHEN-WOLKOWIEZ, Michael; POINDEXTER, Brenda; ARRIETA, Antonio et al.Clinical infectious diseases. 2012, Vol 55, Num 11, pp 1495-1502, issn 1058-4838, 8 p.Article

Can We Use Imipenem and Meropenem Vitek 2 MICs for Detection of Suspected KPC and Other-Carbapenemase Producers among Species of Enterobacteriaceae?PASTERAN, Fernando; LUCERO, Celeste; SOLOAGA, Rolando et al.Journal of clinical microbiology (Print). 2011, Vol 49, Num 2, pp 697-701, issn 0095-1137, 5 p.Article

Comparative Evaluation of a Chromogenic Agar Medium, the Modified Hodge Test, and a Battery of Meropenem-Inhibitor Discs for Detection of Carbapenemase Activity in EnterobacteriaceaeSEAH, Christine; LOW, Donald E; PATEL, Samir N et al.Journal of clinical microbiology (Print). 2011, Vol 49, Num 5, pp 1965-1969, issn 0095-1137, 5 p.Article

Heteroresistance to Meropenem in Carbapenem-Susceptible Acinetobacter baumanniiIKONOMIDIS, Alexandros; NEOU, Evangelia; GOGOU, Vassiliki et al.Journal of clinical microbiology (Print). 2009, Vol 47, Num 12, pp 4055-4059, issn 0095-1137, 5 p.Article

Comparative in vitro pharmacodynamics of imipenem and meropenem against ATCC strains of Escherichia coli, Staphylococcus aureus and Bacteroides fragilisWHITE, Roger L; FRIEDRICH, Lawrence V; MANDURU, Madhavi et al.Diagnostic microbiology and infectious disease. 2001, Vol 39, Num 1, pp 39-47, issn 0732-8893Article

Detection of emerging resistance patterns within longitudinal surveillance systems : data sensitivity and microbial susceptibilityJONES, Ronald N.Journal of antimicrobial chemotherapy (Print). 2000, Vol 46, Num SEP, pp 1-8, issn 0305-7453, NS2Article

Surveillance studies : how can they help the management of infection?MASTERTON, Robert G.Journal of antimicrobial chemotherapy (Print). 2000, Vol 46, Num SEP, pp 53-58, issn 0305-7453, NS2Article

Characteristics of Meropenem Heteroresistance in Klebsiella pneumoniae Carbapenemase (KPC)-Producing Clinical Isolates of K. pneumoniaePOURNARAS, Spyros; KRISTO, Ioulia; VRIONI, Georgia et al.Journal of clinical microbiology (Print). 2010, Vol 48, Num 7, pp 2601-2604, issn 0095-1137, 4 p.Article

Effectiveness of drug use evaluation and antibiotic authorization on patients' clinical outcomes, antibiotic consumption, and antibiotic expendituresRATTANAUMPAWAN, Pinyo; SUTHA, Patama; THAMLIKITKUL, Visanu et al.American journal of infection control. 2010, Vol 38, Num 1, pp 38-43, issn 0196-6553, 6 p.Article

Meropenem Pharmacokinetics in the NewbornVAN DEN ANKER, John N; POKOMA, Pavla; KINZIG-SCHIPPERS, Martina et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 9, pp 3871-3879, issn 0066-4804, 9 p.Article

Update on the Efficacy and Tolerability of Meropenem in the Treatment of Serious Bacterial InfectionsMOHR, John F.Clinical infectious diseases. 2008, Vol 47, issn 1058-4838, S41-S51, SUP1Article